Delia Cangini

ScholarGPS® ID: 81466980008408

Affiliation

Lippincott Williams & Wilkins, Philadelphia, United States

Affiliation History

Field

Medicine

Discipline

Hematology

Top Specialties

Metrics Summary

Publication Count

Predicted Citations

2,994

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Exploring the role of the combination of FDG-PET plus whole body MRI for staging patients with high-risk smoldering myeloma: A prospective trial. (journal article) Cerchione, Claudio \| Nappi, Davide \| Marchesini, Matteo \| Ronconi, Sonia \| Cangini, Delia \| Ceccolini, Michela \| Matteucci, Federica \| Prochowski Iamurri, Andrea \| Simonetti, Giorgia \| Musuraca, Gerardo \| ... \| Rossi, Alice Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 7569-7569 (2024). 10.1200/JCO.2024.42.16_suppl.7569 Cite \| Source
Exploring the role of the combination of FDG PET plus whole body MRI for staging newly diagnosed and relapsed/refractory multiple myeloma: A prospective trial. (journal article) Cerchione, Claudio \| Nappi, Davide \| Marchesini, Matteo \| Cangini, Delia \| Ronconi, Sonia \| Ceccolini, Michela \| Prochowski Iamurri, Andrea \| Matteucci, Federica \| Simonetti, Giorgia \| Musuraca, Gerardo \| ... \| Rossi, Alice Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 7512-7512 (2024). 10.1200/JCO.2024.42.16_suppl.7512 Cite \| Source
Pre-Existing Myeloid Subclones May Account for a Subset of Acute Myeloid Leukemias and Myelodysplastic Neoplasms in Patients with Pre-Existing or Contemporary Lymphoid Disorders (journal article) Mattei, Agnese \| Marconi, Giovanni \| Ronconi, Sonia \| Cangini, Delia \| Ceccolini, Michela \| Cerchione, Claudio \| Zacheo, Irene \| Giannini, Maria Benedetta \| Norata, Marianna \| Martinelli, Giovanni \| ... \| Nappi, Davide Blood, volume 142, issue Supplement 1, pages 1475-1475 (2023). 10.1182/blood-2023-186760 Cited by (1) \| Cite \| Source
P-056 Role the combination of FDG pet plus whole body MRI for staging patients in high risk smoldering myeloma: a prospective trial (journal article) Cerchione, Claudio \| Nappi, Davide \| Marchesini, Matteo \| Ronconi, Sonia \| Cangini, Delia \| Ceccolini, Michela \| Simonetti, Giorgia \| Musuraca, Gerardo \| Martinelli, Giovanni \| Rossi, Alice Clinical Lymphoma Myeloma and Leukemia, volume 23 (2023). 10.1016/S2152-2650(23)01674-9 Cite \| Source
P-057 Role of the combination of FDG-PET plus whole body MRI for staging newly diagnosed and relapsed/refractory multiple myeloma: a prospective trial (journal article) Cerchione, Claudio \| Nappi, Davide \| Marchesini, Matteo \| Ronconi, Sonia \| Cangini, Delia \| Ceccolini, Michela \| Simonetti, Giorgia \| Musuraca, Gerardo \| Martinelli, Giovanni \| Rossi, Alice Clinical Lymphoma Myeloma and Leukemia, volume 23 (2023). 10.1016/S2152-2650(23)01675-0 Cite \| Source
MM-638 Role of the Combination of FDG-PET plus Whole Body MRI for Staging Newly Diagnosed and Relapsed/Refractory Multiple Myeloma (MM): A Prospective Trial (journal article) Cerchione, Claudio \| Nappi, Davide \| Marchesini, Matteo \| Cangini, Delia \| Ronconi, Sonia \| Ceccolini, Michela \| Musuraca, Gerardo \| Martinelli, Giovanni \| Rossi, Alice Clinical Lymphoma Myeloma and Leukemia, volume 23 (2023). 10.1016/S2152-2650(23)01479-9 Cite \| Source
Bendamustine-bortezomib-dexamethasone in relapsed/refractory multiple myeloma. (journal article) Cerchione, Claudio \| Nappi, Davide \| Cangini, Delia \| Ronconi, Sonia \| Ceccolini, Michela \| Musuraca, Gerardo \| Martinelli, Giovanni Journal of Clinical Oncology, volume 41, issue 16_suppl, pages e20051-e20051 (2023). 10.1200/JCO.2023.41.16_suppl.e20051 Cite \| Source
Venetoclax durable response in adult relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia with JAK/STAT pathway alterations (journal article) Ferrari, Anna \| Cangini, Delia \| Ghelli Luserna di Rorà, Andrea \| Condorelli, Annalisa \| Pugliese, Marta \| Schininà, Giovanni \| Cosentino, Sebastiano \| Fonzi, Eugenio \| Domizio, Chiara \| Simonetti, Giorgia \| ... \| Martinelli, Giovanni Frontiers in Cell and Developmental Biology, volume 11 (2023). 10.3389/fcell.2023.1165308 Cited by (1) \| Cite \| Source
Pegfilgrastim Versus Filgrastim in the Supportive Care of Heavily Pretreated Multiple Myeloma in Treatment with Pomalidomide-Dexamethasone (journal article) Cerchione, Claudio \| Nappi, Davide \| Musuraca, Gerardo \| Ronconi, Sonia \| Cangini, Delia \| Ceccolini, Michela \| Martinelli, Giovanni Blood, volume 140, issue Supplement 1, pages 13248-13249 (2022). 10.1182/blood-2022-170561 Cite \| Source
MM-499 Pegfilgrastim Versus Filgrastim in the Supportive Care of Heavily Pretreated Multiple Myeloma in Treatment With Pomalidomide-Dexamethasone (journal article) Cerchione, Claudio \| Catalano, Lucio \| Nappi, Davide \| Ronconi, Sonia \| Cangini, Delia \| Ceccolini, Michela \| Musuraca, Gerardo \| Marchesini, Matteo \| Pane, Fabrizio \| Martinelli, Giovanni Clinical Lymphoma Myeloma and Leukemia, volume 22 (2022). 10.1016/S2152-2650(22)01631-7 Cite \| Source
MM-501 Domestic Opportunity in Heavily Pretreated Multiple Myeloma Not Eligible for Hospital-Based Treatment: Role of Pomalidomide-Dexamethasone (journal article) Cerchione, Claudio \| Catalano, Lucio \| Nappi, Davide \| Ronconi, Sonia \| Cangini, Delia \| Ceccolini, Michela \| Musuraca, Gerardo \| Marchesini, Matteo \| Martinelli, Giovanni Clinical Lymphoma Myeloma and Leukemia, volume 22 (2022). 10.1016/S2152-2650(22)01632-9 Cite \| Source
MM-498 Addition of Carfilzomib as a Third Agent in Lenalidomide-Refractory Multiple Myeloma: Switching From Doublet to Triplet (journal article) Cerchione, Claudio \| Catalano, Lucio \| Nappi, Davide \| Ronconi, Sonia \| Cangini, Delia \| Ceccolini, Michela \| Musuraca, Gerardo \| Marchesini, Matteo \| Pane, Fabrizio \| Martinelli, Giovanni Clinical Lymphoma Myeloma and Leukemia, volume 22 (2022). 10.1016/S2152-2650(22)01630-5 Cite \| Source
MM-494 Chemo or Chemo-Free Regimens in Heavily Pretreated Multiple Myeloma? Role of Bendamustine-Bortezomib-Dexamethasone (BVD) in Novel Agents' Era (journal article) Nappi, Davide \| Catalano, Lucio \| Pareto, Anna Emanuele \| Musuraca, Gerardo \| Ronconi, Sonia \| Ceccolini, Michela \| Cangini, Delia \| Pane, Fabrizio \| Martinelli, Giovanni Clinical Lymphoma Myeloma and Leukemia, volume 22 (2022). 10.1016/S2152-2650(22)01629-9 Cite \| Source
P-236: Addition of carfilzomib as a third agent in lenalidomide-refractory multiple myeloma: switching from doublet to triplet (journal article) Cerchione, Claudio \| Catalano, lucio \| Nappi, Davide \| Musuraca, Gearardo \| Ronconi, Sonia \| Ceccolini, Michela \| Cangini, Delia \| Marchesini, Matteo \| pane, Fabrizio \| Martinelli, Giovanni Clinical Lymphoma Myeloma and Leukemia, volume 22 (2022). 10.1016/S2152-2650(22)00566-3 Cite \| Source
P-235: Chemo or chemo-free regimens in heavily pretreated multiple myeloma? Role of bendamustine-bortezomib-dexamethasone (BVD) in novel agents’ era (journal article) Cerchione, Claudio \| Catalano, lucio \| Nappi, Davide \| Musuraca, Gearardo \| Ronconi, Sonia \| Ceccolini, Michela \| Cangini, Delia \| Marchesini, Matteo \| pane, Fabrizio \| Martinelli, Giovanni Clinical Lymphoma Myeloma and Leukemia, volume 22 (2022). 10.1016/S2152-2650(22)00565-1 Cite \| Source
P-185: Domestic opportunity in heavily pretreated multiple myeloma not eligible to hospitalbased treatment: role of pomalidomide-dexamethasone (journal article) Cerchione, Claudio \| Nappi, Davide \| Catalano, lucio \| Musuraca, Gearardo \| Ronconi, Sonia \| Cangini, Delia \| Ceccolini, Michela \| Marchesini, Matteo \| pane, Fabrizio \| Martinelli, Giovanni Clinical Lymphoma Myeloma and Leukemia, volume 22 (2022). 10.1016/S2152-2650(22)00515-8 Cite \| Source
P-184: Pegfilgrastim versus filgrastim in the supportive care of heavily pretreated multiple myeloma in treatment with pomalidomide-dexamethasone (journal article) Cerchione, Claudio \| Catalano, lucio \| Nappi, Davide \| Musuraca, Gearardo \| Ronconi, Sonia \| Cangini, Delia \| Ceccolini, Michela \| Marchesini, Matteo \| pane, Fabrizio \| Martinelli, Giovanni Clinical Lymphoma Myeloma and Leukemia, volume 22 (2022). 10.1016/S2152-2650(22)00514-6 Cite \| Source
Addition of carfilzomib as a third agent in lenalidomide-refractory multiple myeloma: Switching from doublet to triplet. (journal article) Cerchione, Claudio \| Nappi, Davide \| Catalano, Lucio \| Ronconi, Sonia \| Cangini, Delia \| Ceccolini, Michela \| Musuraca, Gerardo \| Martinelli, Giovanni Journal of Clinical Oncology, volume 40, issue 16_suppl, pages e20002-e20002 (2022). 10.1200/JCO.2022.40.16_suppl.e20002 Cited by (1) \| Cite \| Source
Chemo or chemo-free regimens in heavily pretreated multiple myeloma? Role of bendamustine-bortezomib-dexamethasone (BVD) in NOVEL agents' era. (journal article) Cerchione, Claudio \| Catalano, Lucio \| Nappi, Davide \| Ronconi, Sonia \| Cangini, Delia \| Ceccolini, Michela \| Musuraca, Gerardo \| Martinelli, Giovanni Journal of Clinical Oncology, volume 40, issue 16_suppl, pages e20010-e20010 (2022). 10.1200/JCO.2022.40.16_suppl.e20010 Cite \| Source
PB1987: DOMESTIC OPPORTUNITY IN HEAVILY PRETREATED MULTIPLE MYELOMA NOT ELIGIBLE TO HOSPITAL-BASED TREATMENT: ROLE OF POMALIDOMIDE-DEXAMETHASONE (journal article) Cerchione, C. \| Nappi, D. \| Pareto, A. E. \| Ronconi, S. \| Cangini, D. \| Ceccolini, M. \| Musuraca, G. \| Catalano, L. \| Martinelli, G. HemaSphere, volume 6 (2022). 10.1097/01.HS9.0000850784.48218.49 Cite \| Source